Complete Genomics announced today that it has raised $39 million in its Series E funding round. New investor Sands Capital led this round of financing and was joined by existing investors Essex Woodlands, OVP Venture Partners, Prospect Venture Partners, OrbiMed Advisors, Highland Capital Management and Enterprise Partners. Complete Genomics also reported that it is evaluating […]
Max Planck Innovation and ibidi sign license agreement for cytoskeleton research Max Planck Innovation GmbH, the technology transfer organization of the Max Planck Society, has awarded an exclusive license for LifeAct to ibidi GmbH, a provider of cell analysis products, located in Martinsried near Munich. The novel peptide allows for actin, an important protein, to […]
SUNNYVALE, Calif. – Cepheid (Nasdaq: CPHD) announced today that it has filed an answer and counterclaims in a patent suit brought by Abaxis on June 28, 2010 in the United States District Court for the Northern District of California. In its filing, Cepheid denied Abaxis’ allegations of patent infringement, asked the Court to determine it […]
Paris – Cellectis (Alternext: ALCLS), the French genome engineering specialist, announced today that the Paris Tribunal de Grande Instance has dismissed the claims filed by Taconic Artemis and Taconic Farms Inc. in December 2008 against Cellectis’ termination for breach of its license to homologous recombination patents. The third chamber of the Tribunal de Grande Instance […]
Celsis In Vitro, Inc. (Celsis IVT) announced today that it has filed a patent infringement lawsuit against Invitrogen Corporation (Invitrogen) and CellzDirect, Inc. (CellzDirect) in the United States District Court for the Northern District of Illinois in Chicago and has moved for a preliminary injunction. Invitrogen, the parent of CellzDirect, is itself a wholly-owned subsidiary […]
Tokyo Customs officially accepted a petition filed by Hitachi High-Technologies Corporation (TOKYO:8036, Hitachi High-Tech) to prohibit the import of FIB/SEM* systems produced by U.S.-based FEI Company to Japan. Hitachi High-Technologies initially filed the petition for an injunction with Tokyo Customs on February 10, 2010, based on claims that the FEI/SEM systems produced by FEI Company […]
Successful Conclusion Eliminates Overhang of 1,000,000 Shares of Series E Preferred Stock With a Liquidation Value of $5 Million WILMINGTON, MA – Implant Sciences Corporation (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for the homeland security and defense markets, today announced the successful resolution of litigation stemming from its sale of Accurel […]
RESEARCH TRIANGLE PARK, North Carolina — Precision BioSciences, Inc., today announced that the United States Patent and Trademark Office (PTO) has now issued Actions Closing Prosecution in the reexamination proceedings for both U.S. Pat. No. 6,610,545 (“the ‘545 patent”) and U.S. Pat. No. 7,309,605 (“the ‘605 patent”) that are owned by the Institut Pasteur and […]
GERMANTOWN, Maryland and HILDEN, Germany — — QIAGEN N.V. (NASDAQ: QGEN [ https://quotes.nasdaq.com/asp/SummaryQuote.asp?symbol=QGEN&selected=QGEN ]; Frankfurt, Prime Standard: QIA [ https://www.boerse-frankfurt.de/DE/index.aspx?pageID=35&ISIN=NL0000240000 ]) today announced that it has signed an agreement with Roche Molecular Systems Inc., a unit of Roche Holding AG (ROG.VX [ https://www.reuters.com/finance/stocks/overview?symbol=ROG.VX ]), resolving a dispute over distribution rights for a set of companion […]
Supports Current Products and Applications in Food Safety, Pharmaceutical Development, and Forensics Saugus, MA –(PR.com)– IonSense, Inc. is pleased to announce that the U.S. Patent Office has awarded three patents supporting its Direct Analysis in Real Time (or DART®) mass spectrometry products. The company’s DART ion sources and application accessories enable the fast, simple analysis […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
